Latest California Healthline Stories
It’s never easy to tell a patient about a terminal illness, but a longtime doctor whose own diagnosis was botched says physicians must do better.
The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
The widespread availability of naloxone, which reverses overdoses, has radically changed the culture of opioid use on the streets, giving drug users a sense of security and inducing them to seek out the more powerful high of the synthetic opioid fentanyl.
The Affordable Care Act and other federal laws sought to put mental health care on an equal footing with physical health. But patients are still finding that’s not the case.
School psychologists provide the first line of treatment for children with mental health issues. Quantifying the shortage depends on who’s counting.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
For Central American migrants who follow U.S. government rules for pursuing asylum, conditions on the Mexican side of the border are sweltering, filled with anxiety and illness. Few people have a clear timetable for when it will get any better.
Many therapists are not familiar with two key treatment options for trauma recommended by the American Psychiatric Association and the Department of Veterans Affairs.